Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Targeted Radiopharmaceuticals Summit US (TRP) – Boston, […]
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Targeted Radiopharmaceuticals Summit US (TRP) – Boston, […]
June 25, 2023 – For the second year in a row, the spotlight shone on […]
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2023 Annual SNMMI Meeting – Chicago, Illinois
June […]
LAKE ZURICH, Il. and DULLES, Va. — June 21, 2023, RLS (USA), […]
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 14, 2023 Download the Presentation […]
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Dear FAPI community,
This quarter, the FAPI team celebrated […]
SOFIE has added BAMF Health, a novel cancer treatment center in Grand Rapids, Michigan, as […]
Dulles, VA –May 12, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
Presented by: Prof. Dr. Frederik L. Giesel, MD, MBA; Chair of Nuclear Medicine, Department of […]
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Informa Connect: Radiopharmaceuticals and Imaging Digital Conference
March […]